Pipeline
Transformative medicines discovered and developed at the intersection of experimentation and AI.
Each of our medicines is a completely new chemical scaffold, allowing us to solve problems others cannot and treat diseases that affect large patient populations.
De novo medicines
Internally, we are advancing a pipeline of de novo medicines for immune system diseases. For partners, we are delivering de novo medicines across broad therapeutic areas — with multiple milestones already achieved.
Partnering
Contact us to learn how partnering with Terray can accelerate your work.
Updates